KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Common Equity (2016 - 2026)

Globus Medical filings provide 15 years of Common Equity readings, the most recent being $4.6 billion for Q4 2025.

  • On a quarterly basis, Common Equity rose 9.48% to $4.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.6 billion, a 9.48% increase, with the full-year FY2025 number at $4.6 billion, up 9.48% from a year prior.
  • Common Equity hit $4.6 billion in Q4 2025 for Globus Medical, up from $4.4 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $4.6 billion in Q4 2025 to a low of $1.6 billion in Q1 2021.
  • Median Common Equity over the past 5 years was $3.0 billion (2023), compared with a mean of $3.0 billion.
  • Biggest five-year swings in Common Equity: skyrocketed 137.36% in 2023 and later fell 2.82% in 2024.
  • Globus Medical's Common Equity stood at $1.7 billion in 2021, then increased by 6.03% to $1.8 billion in 2022, then soared by 116.53% to $4.0 billion in 2023, then grew by 4.49% to $4.2 billion in 2024, then grew by 9.48% to $4.6 billion in 2025.
  • The last three reported values for Common Equity were $4.6 billion (Q4 2025), $4.4 billion (Q3 2025), and $4.3 billion (Q2 2025) per Business Quant data.